Abstract
Cell culture processes play a central role in the production of various therapeutic compounds. These processes are multiscale and highly complex, making them challenging to describe comprehensively using fully mechanistic models. In this study, we employ an integrated hybrid machine learning and first principles model to predict the viable cell density, product titer, and metabolite concentration profiles. We employ the concept of degree of hybridization, where we create a family of hybrid models each with increasing degree of process knowledge. Predictions from the feasible hybrid architecture were integrated with a genome scale metabolic model to evaluate the flux distribution of reactions related to the central carbon metabolism of the cell throughout the process duration. We demonstrate that the current approach not only reasonably predicts the bioprocess profile but also provides biologically relevant information that can uncover dynamics of intracellular metabolism which can open opportunities for new optimization strategies.